Quantitative Estimation of Hair Growth: Androgenetic Alopecia in Women and the Effect of Minoxidil

    Vera H. Price, Emory Menefee
    Image of study
    TLDR Minoxidil promotes hair growth in women with early-stage alopecia.
    The document reports on various studies that investigated the effect of minoxidil on hair growth in women with androgenetic alopecia. The studies found that minoxidil is effective in promoting hair growth, particularly in women with stage I and II alopecia. The most reliable estimator for hair growth was found to be the total weight of hair, and accurate sampling procedures are important for reliable results. The studies recommend a test period of at least 32 weeks and using a larger sample size to establish measurement standards for hair growth.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 1000+ results

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 7 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 8 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community New Treatments, and a Huge Group Buy with Lots of Research

      in Research/Science  109 upvotes 1 year ago
      A user is organizing a group buy for various compounds aimed at reversing hair loss and gray hair, and improving brain health and fat loss. The user has developed a treatment plan based on extensive research and is inviting others to participate, with the option to choose only the compounds they need.
      The story of RU58841/ PSK3841

      community The story of RU58841/ PSK3841

      in Research  622 upvotes 4 months ago
      RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.

    Related Research

    9 / 9 results